UnitedHealth Group Inc (NYSE:UNH) Position Increased by Winslow Evans & Crocker Inc.
Winslow Evans & Crocker Inc. raised its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 1.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,952 shares of the healthcare conglomerate’s stock after purchasing an additional 108 shares during the period. Winslow Evans & Crocker Inc.’s holdings in UnitedHealth Group were worth $1,698,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Diamond Hill Capital Management Inc. boosted its stake in shares of UnitedHealth Group by 13.8% in the fourth quarter. Diamond Hill Capital Management Inc. now owns 997 shares of the healthcare conglomerate’s stock worth $248,000 after buying an additional 121 shares during the last quarter. Prime Capital Investment Advisors LLC lifted its holdings in UnitedHealth Group by 1,500.0% in the fourth quarter. Prime Capital Investment Advisors LLC now owns 1,200 shares of the healthcare conglomerate’s stock valued at $299,000 after acquiring an additional 1,125 shares during the period. Bremer Trust National Association lifted its holdings in UnitedHealth Group by 14.0% in the fourth quarter. Bremer Trust National Association now owns 9,464 shares of the healthcare conglomerate’s stock valued at $2,358,000 after acquiring an additional 1,159 shares during the period. South State Corp boosted its position in UnitedHealth Group by 8.1% in the 4th quarter. South State Corp now owns 3,296 shares of the healthcare conglomerate’s stock worth $822,000 after purchasing an additional 247 shares in the last quarter. Finally, Los Angeles Capital Management & Equity Research Inc. boosted its position in UnitedHealth Group by 0.6% in the 4th quarter. Los Angeles Capital Management & Equity Research Inc. now owns 1,008,247 shares of the healthcare conglomerate’s stock worth $251,174,000 after purchasing an additional 5,848 shares in the last quarter. 85.87% of the stock is currently owned by institutional investors.
A number of analysts recently issued reports on the stock. Citigroup reissued a “buy” rating on shares of Healthequity in a report on Friday, May 10th. Zacks Investment Research raised shares of Falcon Minerals from a “sell” rating to a “hold” rating in a report on Monday, July 22nd. UBS Group set a $36.00 price objective on shares of Halliburton and gave the stock a “buy” rating in a research report on Tuesday, April 23rd. Cantor Fitzgerald set a $620.00 target price on shares of Intuitive Surgical and gave the stock a “buy” rating in a research note on Friday, July 19th. Finally, Raymond James reissued a “buy” rating on shares of West Fraser Timber in a research note on Friday, July 19th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have given a buy rating to the stock. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $295.06.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, beating analysts’ consensus estimates of $3.46 by $0.14. The business had revenue of $60.60 billion during the quarter, compared to analysts’ expectations of $60.59 billion. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The business’s revenue was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $3.14 earnings per share. As a group, equities analysts anticipate that UnitedHealth Group Inc will post 14.82 earnings per share for the current fiscal year.
In other UnitedHealth Group news, Director Frederick William Mcnabb III purchased 6,430 shares of the stock in a transaction that occurred on Wednesday, May 1st. The shares were purchased at an average cost of $233.21 per share, for a total transaction of $1,499,540.30. Following the completion of the transaction, the director now owns 7,879 shares of the company’s stock, valued at approximately $1,837,461.59. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO David S. Wichmann acquired 20,000 shares of the company’s stock in a transaction that occurred on Friday, May 3rd. The shares were acquired at an average cost of $231.79 per share, with a total value of $4,635,800.00. Following the purchase, the chief executive officer now owns 904,367 shares in the company, valued at approximately $209,623,226.93. The disclosure for this purchase can be found here. Insiders have sold 37,000 shares of company stock valued at $9,158,720 over the last quarter. 0.82% of the stock is owned by company insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: What is the return on assets formula?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.